Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-12-002940
Filing Date
2012-03-29
Accepted
2012-03-29 06:36:08
Documents
12
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tlon_10k-123111.htm 10-K 2075484
2 EXHIBIT 10.4 ex10-4.htm EX-10.4 7448
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 4503
4 EXHIBIT 31.1 ex31-1.htm EX-31.1 15691
5 EXHIBIT 31.2 ex31-2.htm EX-31.2 15766
6 EXHIBIT 32.1 ex32-1.htm EX-32.1 8766
  Complete submission text file 0001437749-12-002940.txt   6338067

Data Files

Seq Description Document Type Size
7 tlonob-20111231.xml EX-101.INS 1063027
8 tlonob-20111231.xsd EX-101.SCH 25390
9 tlonob-20111231_cal.xml EX-101.CAL 28297
10 tlonob-20111231_def.xml EX-101.DEF 107777
11 tlonob-20111231_lab.xml EX-101.LAB 156605
12 tlonob-20111231_pre.xml EX-101.PRE 124982
Mailing Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404
Business Address 2207 BRIDGEPOINTE PARKWAY SUITE 250 SAN MATEO CA 94404 650-588-6404
Talon Therapeutics, Inc. (Filer) CIK: 0001140028 (see all company filings)

EIN.: 320064979 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32626 | Film No.: 12722238
SIC: 2834 Pharmaceutical Preparations